239 related articles for article (PubMed ID: 28188341)
21. Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes.
Jetten MJ; Kleinjans JC; Claessen SM; Chesné C; van Delft JH
Toxicol In Vitro; 2013 Oct; 27(7):2031-40. PubMed ID: 23911569
[TBL] [Abstract][Full Text] [Related]
22. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a Drug-Induced, Bile Acid-Dependent Hepatotoxicity Model Using HepaRG Cells.
Susukida T; Sekine S; Nozaki M; Tokizono M; Oizumi K; Horie T; Ito K
J Pharm Sci; 2016 Apr; 105(4):1550-60. PubMed ID: 26952880
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.
Bell CC; Lauschke VM; Vorrink SU; Palmgren H; Duffin R; Andersson TB; Ingelman-Sundberg M
Drug Metab Dispos; 2017 Apr; 45(4):419-429. PubMed ID: 28137721
[TBL] [Abstract][Full Text] [Related]
25. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease.
Bell CC; Hendriks DF; Moro SM; Ellis E; Walsh J; Renblom A; Fredriksson Puigvert L; Dankers AC; Jacobs F; Snoeys J; Sison-Young RL; Jenkins RE; Nordling Å; Mkrtchian S; Park BK; Kitteringham NR; Goldring CE; Lauschke VM; Ingelman-Sundberg M
Sci Rep; 2016 May; 6():25187. PubMed ID: 27143246
[TBL] [Abstract][Full Text] [Related]
26. Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.
Sharanek A; Burban A; Humbert L; Bachour-El Azzi P; Felix-Gomes N; Rainteau D; Guillouzo A
Toxicol Sci; 2015 Oct; 147(2):573-87. PubMed ID: 26198044
[TBL] [Abstract][Full Text] [Related]
27. Combination of molecular docking and liver transcription sequencing analysis for the evaluation of salt-processed psoraleae fructus-induced hepatotoxicity in ovariectomized mice.
Wu Y; Min L; Xu Y; Liu H; Zhou N; Hua Z; Mei C; Jiang Z; Li W
J Ethnopharmacol; 2022 Apr; 288():114955. PubMed ID: 35032590
[TBL] [Abstract][Full Text] [Related]
28. Impact of inflammation on chlorpromazine-induced cytotoxicity and cholestatic features in HepaRG cells.
Bachour-El Azzi P; Sharanek A; Abdel-Razzak Z; Antherieu S; Al-Attrache H; Savary CC; Lepage S; Morel I; Labbe G; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2014 Sep; 42(9):1556-66. PubMed ID: 25002748
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine A treated in vitro models induce cholestasis response through comparison of phenotype-directed gene expression analysis of in vivo Cyclosporine A-induced cholestasis.
Kienhuis AS; Vitins AP; Pennings JL; Pronk TE; Speksnijder EN; Roodbergen M; van Delft JH; Luijten M; van der Ven LT
Toxicol Lett; 2013 Aug; 221(3):225-36. PubMed ID: 23830897
[TBL] [Abstract][Full Text] [Related]
30. Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development.
Donato MT; López-Riera M; Castell JV; Gómez-Lechón MJ; Jover R
Toxicol Lett; 2016 Nov; 263():58-67. PubMed ID: 27765674
[TBL] [Abstract][Full Text] [Related]
31. Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability.
Hendriks DF; Fredriksson Puigvert L; Messner S; Mortiz W; Ingelman-Sundberg M
Sci Rep; 2016 Oct; 6():35434. PubMed ID: 27759057
[TBL] [Abstract][Full Text] [Related]
32. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.
Susukida T; Sekine S; Nozaki M; Tokizono M; Ito K
Drug Metab Dispos; 2015 Nov; 43(11):1760-8. PubMed ID: 26329788
[TBL] [Abstract][Full Text] [Related]
33. Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis.
Karsten REH; Krijnen NJW; Maho W; Permentier H; Verpoorte E; Olinga P
Arch Toxicol; 2022 Sep; 96(9):2523-2543. PubMed ID: 35708773
[TBL] [Abstract][Full Text] [Related]
34. Exploring Chronic Drug Effects on Microengineered Human Liver Cultures Using Global Gene Expression Profiling.
Ware BR; McVay M; Sunada WY; Khetani SR
Toxicol Sci; 2017 Jun; 157(2):387-398. PubMed ID: 28369597
[TBL] [Abstract][Full Text] [Related]
35. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
[TBL] [Abstract][Full Text] [Related]
36. Early indications of ANIT-induced cholestatic liver injury: Alteration of hepatocyte polarization and bile acid homeostasis.
Yang T; Mei H; Xu D; Zhou W; Zhu X; Sun L; Huang X; Wang X; Shu T; Liu J; Ding J; Hassan HM; Zhang L; Jiang Z
Food Chem Toxicol; 2017 Dec; 110():1-12. PubMed ID: 28986171
[TBL] [Abstract][Full Text] [Related]
37. Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 cells.
Liguori MJ; Blomme EA; Waring JF
Drug Metab Dispos; 2008 Feb; 36(2):223-33. PubMed ID: 17967932
[TBL] [Abstract][Full Text] [Related]
38. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.
Woolbright BL; Jaeschke H
Methods Mol Biol; 2015; 1250():363-76. PubMed ID: 26272158
[TBL] [Abstract][Full Text] [Related]
39. Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury?
Holman NS; Mosedale M; Wolf KK; LeCluyse EL; Watkins PB
Toxicol Sci; 2016 Jun; 151(2):365-75. PubMed ID: 26962055
[TBL] [Abstract][Full Text] [Related]
40. Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals.
Vilas-Boas V; Gijbels E; Leroy K; Pieters A; Baze A; Parmentier C; Vinken M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
